Stevanato Group

Activities: Pharmaceutical

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    What is ISO 8 cleanroom classification? Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
  2. Ansell launches EN ISO 374-1:2016 compliant gloves PPE expert Ansell has launched its new chemical-resistant AlphaTec 53-002 and 53-003 gloves that use MICROCHEM Technology
  3. CAR T-cell therapy: contamination control & role of PPE CAR T-cell therapy, an innovative approach to treating certain types of cancer, relies on the genetic modification of a patient's immune cells to target and destroy cancer...
  4. Engineering firm Dornan makes Royal Institution of Chartered Surveyors history Dornan has been the first MEP contractor in Ireland to receive the RISE Corporate Support Scheme Badge from the Royal Institution of Chartered Surveyors
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Integrity testing of HEPA filters: A practical approach Filtering the air in aseptic process areas is critical to maintaining the cleanliness of the production environment. Jesus Casas provides tips to ensure HEPA filters are fit...

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

Related Content

Containment

Quantoom joins forces with Stevanato to elevate mRNA contained production platform

The glass packaging expert Stevanato Group has agreed to work with Quantoom to elevate its mRNA production Nfinity Platform
Packaging

Stevanato joins forces with Pfeiffer on container-closure systems testing

Joint endeavour will provide characterisation testing of container-closure systems for the biopharma industry
Packaging

Ompi and SiO2 Medical Products sign collaboration agreement

The partnership will give pharmaceutical and biological customers access to extended supplier offering for fill-finish and a faster drug product time-to-market
Subscribe now